[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Tetracaine.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Warfarin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Benzyl alcohol.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Acenocoumarol.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Dicoumarol.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Tioclomarol.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Oxybuprocaine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Capsaicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Chloroprocaine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Dyclonine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Cocaine.]
[M03AC11, cisatracurium, Chloramphenicol succinate may increase the neuromuscular blocking activities of Cisatracurium.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Diphenhydramine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Ropivacaine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Etidocaine.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Fluindione.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Articaine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Lidocaine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Mepivacaine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Phenprocoumon.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Prilocaine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Procaine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Chloramphenicol.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Chloramphenicol.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Chloramphenicol.]
[L04AA27, fingolimod, Chloramphenicol may increase the immunosuppressive activities of Fingolimod.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Chloramphenicol.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Chloramphenicol.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Chloramphenicol.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mercaptopurine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Chloramphenicol.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Chloramphenicol.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Chloramphenicol.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Chloramphenicol.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Tetracaine.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Chloramphenicol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Chloramphenicol.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Chloramphenicol.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Eribulin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Chloramphenicol.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Chloramphenicol.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Chloramphenicol.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Chloramphenicol.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Chloramphenicol.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Chloramphenicol.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Chloramphenicol.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Chloramphenicol.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Chloramphenicol.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Chloramphenicol.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Chloramphenicol.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Triamcinolone.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Chloramphenicol.]
[C03AA06, trichlormethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Chloramphenicol.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Chloramphenicol.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Chloramphenicol.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Chloramphenicol.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Chloramphenicol.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Chloramphenicol.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Belimumab.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Chloramphenicol.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Chloramphenicol.]
[J05AP03, boceprevir, The metabolism of Boceprevir can be decreased when combined with Chloramphenicol.]
[J05AP02, telaprevir, The metabolism of Telaprevir can be decreased when combined with Chloramphenicol.]
[J05AG05, rilpivirine, The metabolism of Rilpivirine can be decreased when combined with Chloramphenicol.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Chloramphenicol.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Belatacept.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Chloramphenicol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Chloramphenicol.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Chloramphenicol.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Chloramphenicol.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Chloramphenicol.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Chloramphenicol.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Chloramphenicol.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Chloramphenicol.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Chloramphenicol.]
[J05AE02, indinavir, The metabolism of Indinavir can be decreased when combined with Chloramphenicol.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Chloramphenicol.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Chloramphenicol.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Chloramphenicol.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Chloramphenicol.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be decreased when combined with Chloramphenicol.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Chloramphenicol.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Chloramphenicol.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Chloramphenicol.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Chloramphenicol.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Chloramphenicol.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Chloramphenicol.]
[J02AC03, voriconazole, The metabolism of Voriconazole can be decreased when combined with Chloramphenicol.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Chloramphenicol.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Chloramphenicol.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Chloramphenicol.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Chloramphenicol.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Chloramphenicol.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Cobicistat can be decreased when combined with Chloramphenicol.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Chloramphenicol.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Chloramphenicol.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Chloramphenicol.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Chloramphenicol.]
[N05CA04, barbital, The metabolism of Barbital can be decreased when combined with Chloramphenicol.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Bendamustine.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Chloramphenicol.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Chloramphenicol.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Chloramphenicol.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Chloramphenicol.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Chloramphenicol.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Chloramphenicol.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Chloramphenicol.]
[C03AA01, bendroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Chloramphenicol.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Chloramphenicol.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dimethyl fumarate.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Benzocaine.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Chloramphenicol.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Chloramphenicol.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Benzyl alcohol.]
[L03AA14, lipegfilgrastim, Chloramphenicol may increase the myelosuppressive activities of Lipegfilgrastim.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Chloramphenicol.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Chloramphenicol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Chloramphenicol.]
[L04AA32, apremilast, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Apremilast.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Chloramphenicol.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Chloramphenicol.]
[L04AC11, siltuximab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Chloramphenicol.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Chloramphenicol.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Chloramphenicol.]
[L01XH04, belinostat, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Belinostat.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Chloramphenicol.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Peginterferon beta-1a.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Chloramphenicol.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Chloramphenicol.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Chloramphenicol.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Blinatumomab.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Chloramphenicol.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Chloramphenicol is combined with Dicoumarol.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Chloramphenicol.]
[L04AC10, secukinumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Chloramphenicol.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Chloramphenicol.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Chloramphenicol.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Chloramphenicol.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Chloramphenicol is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Chloramphenicol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Chloramphenicol.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Chloramphenicol.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Chloramphenicol.]
[G02CX02, flibanserin, The serum concentration of Flibanserin can be increased when it is combined with Chloramphenicol.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Chloramphenicol.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Chloramphenicol.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Chloramphenicol.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Chloramphenicol.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Chloramphenicol.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Chloramphenicol.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Chloramphenicol.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Chloramphenicol.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Chloramphenicol.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Chloramphenicol.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Chloramphenicol.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Chloramphenicol.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Chloramphenicol.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Chloramphenicol.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Chloramphenicol.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Chloramphenicol.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Chloramphenicol.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Chloramphenicol.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Chloramphenicol.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Chloramphenicol.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Chloramphenicol.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Chloramphenicol.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Chloramphenicol.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Oxybuprocaine.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Chloramphenicol.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Linezolid.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Chloramphenicol.]
[L04AB02, infliximab, The risk or severity of adverse effects can be increased when Infliximab is combined with Chloramphenicol.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Chloramphenicol.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Chloramphenicol.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Sarilumab.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Chloramphenicol.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Chloramphenicol.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Chloramphenicol.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Chloramphenicol.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Chloramphenicol.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Chloramphenicol.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Chloramphenicol.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Chloramphenicol.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Chloramphenicol.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Chloramphenicol.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Capsaicin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Chloramphenicol.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Chloramphenicol.]
[R05CB03, carbocysteine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Carbocisteine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Chloramphenicol.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Chloramphenicol.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Baricitinib.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Chloramphenicol.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Chloramphenicol.]
[N03AX17, stiripentol, The metabolism of Stiripentol can be decreased when combined with Chloramphenicol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Chloramphenicol.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Chloramphenicol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Chloramphenicol.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Chloramphenicol.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Chloroprocaine.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Chloramphenicol.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Chloramphenicol.]
[L04AA39, emapalumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Chloramphenicol.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Chloramphenicol.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Chloramphenicol.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Chloramphenicol.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Chloramphenicol.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Chloramphenicol.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Chloramphenicol.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Chloramphenicol.]
[J01FA09, clarithromycin, The metabolism of Clarithromycin can be decreased when combined with Chloramphenicol.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Chloramphenicol.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Chloramphenicol.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cloprednol.]
[L04AB01, etanercept, The risk or severity of adverse effects can be increased when Etanercept is combined with Chloramphenicol.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Risankizumab.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Chloramphenicol.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Chloramphenicol.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Chloramphenicol.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Chloramphenicol.]
[J01DD02, ceftazidime, The therapeutic efficacy of Ceftazidime can be decreased when used in combination with Chloramphenicol.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Chloramphenicol.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Upadacitinib.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Chloramphenicol.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Chloramphenicol.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Chloramphenicol.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Chloramphenicol.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Chloramphenicol.]
[C03AA09, cyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Chloramphenicol.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Chloramphenicol.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Chloramphenicol.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Chloramphenicol.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Chloramphenicol.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Chloramphenicol.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Chloramphenicol.]
[N03AX25, cenobamate, The metabolism of Cenobamate can be decreased when combined with Chloramphenicol.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Chloramphenicol.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Chloramphenicol.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Teprotumumab.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Chloramphenicol.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Chloramphenicol.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Chloramphenicol.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Chloramphenicol.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Chloramphenicol.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Chloramphenicol.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Antilymphocyte immunoglobulin (horse).]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluprednidene.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Chloramphenicol.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Chloramphenicol is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Dyclonine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Stepronin.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Chloramphenicol.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Chloramphenicol.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Chloramphenicol.]
[L04AC19, satralizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Satralizumab.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Chloramphenicol.]
[C03AA04, chlorothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Chloramphenicol.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Chloramphenicol.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Chloramphenicol.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Chloramphenicol.]
[A16AX20, lonafarnib, The metabolism of Lonafarnib can be decreased when combined with Chloramphenicol.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fludarabine.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Chloramphenicol.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Voclosporin.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Chloramphenicol.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Chloramphenicol.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Chloramphenicol.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Chloramphenicol.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Chloramphenicol.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ponesimod.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chloramphenicol.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Chloramphenicol.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Chloramphenicol.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cisplatin.]
[N06AB04, citalopram, The serum concentration of Citalopram can be increased when it is combined with Chloramphenicol.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pegcetacoplan.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Chloramphenicol.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Belumosudil.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Chloramphenicol.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Anifrolumab.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Chloramphenicol.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Chloramphenicol.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Chloramphenicol.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Chloramphenicol.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Chloramphenicol.]
[N06AX25, St. John's wort extract, The metabolism of St. John's Wort can be decreased when combined with Chloramphenicol.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Chloramphenicol.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Chloramphenicol.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Levobupivacaine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Chloramphenicol.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Chloramphenicol.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Chloramphenicol.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Chloramphenicol.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Deucravacitinib.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Chloramphenicol.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Chloramphenicol is combined with Clozapine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Cocaine.]
[L04AC21, bimekizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Bimekizumab.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Chloramphenicol.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Chloramphenicol.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Telithromycin can be decreased when combined with Chloramphenicol.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Indobufen is combined with Chloramphenicol.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Chloramphenicol.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Chloramphenicol.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Imatinib.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Chloramphenicol.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Meprednisone.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Chloramphenicol.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Chloramphenicol.]
[C03AA07, cyclopenthiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Chloramphenicol.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Chloramphenicol.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Chloramphenicol.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Chloramphenicol.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Chloramphenicol.]
[N06BA07, modafinil, The metabolism of Modafinil can be decreased when combined with Chloramphenicol.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Chloramphenicol.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Chloramphenicol.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Cytarabine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Chloramphenicol.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dactinomycin.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Chloramphenicol.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Daunorubicin.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Chloramphenicol.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Chloramphenicol.]
[M03AC11, cisatracurium, Chloramphenicol may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Chloramphenicol.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Chloramphenicol.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Chloramphenicol.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Desoximetasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Oxaliplatin.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Chloramphenicol.]
[L04AB04, adalimumab, The risk or severity of adverse effects can be increased when Adalimumab is combined with Chloramphenicol.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Chloramphenicol.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Chloramphenicol.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Chloramphenicol.]
[B01AC04, clopidogrel, The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Chloramphenicol resulting in a loss in efficacy.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Chloramphenicol.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Cinchocaine.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Chloramphenicol.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Chloramphenicol.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Chloramphenicol.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Chloramphenicol.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pirarubicin.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Difluocortolone.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Chloramphenicol.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Chloramphenicol.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Chloramphenicol.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Chloramphenicol.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Lenalidomide.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Chloramphenicol.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Chloramphenicol.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Chloramphenicol.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Chloramphenicol.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Chloramphenicol.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Chloramphenicol.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Chloramphenicol.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Natalizumab.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Chloramphenicol.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Chloramphenicol.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Chloramphenicol.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Chloramphenicol.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be decreased when combined with Chloramphenicol.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Chloramphenicol.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Chloramphenicol.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Chloramphenicol.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Chloramphenicol.]
[R03AC12, salmeterol, The metabolism of Salmeterol can be decreased when combined with Chloramphenicol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Chloramphenicol.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Chloramphenicol.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Chloramphenicol.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Chloramphenicol.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Chloramphenicol.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Chloramphenicol.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Temozolomide.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Chloramphenicol.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Chloramphenicol.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Chloramphenicol.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Chloramphenicol.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Chloramphenicol.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Chloramphenicol.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Chloramphenicol.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Chloramphenicol.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Chloramphenicol.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Carboplatin.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Chloramphenicol.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Chloramphenicol.]
[S01AA17, erythromycin, The therapeutic efficacy of Erythromycin can be decreased when used in combination with Chloramphenicol.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Chloramphenicol.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Chloramphenicol.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Estramustine.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Chloramphenicol.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Chloramphenicol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Chloramphenicol.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Chloramphenicol.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Chloramphenicol.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Chloramphenicol.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Chloramphenicol.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Chloramphenicol.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Chloramphenicol.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Chloramphenicol.]
[C08CA02, felodipine, The metabolism of Felodipine can be decreased when combined with Chloramphenicol.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Chloramphenicol.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Chloramphenicol.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Chloramphenicol.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fludrocortisone.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Chloramphenicol.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Chloramphenicol.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Fluorouracil.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Chloramphenicol.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Chloramphenicol.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Chloramphenicol.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Chloramphenicol.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Chloramphenicol.]
[N03AA04, barbexaclone, The metabolism of Barbexaclone can be decreased when combined with Chloramphenicol.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Chloramphenicol.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Chloramphenicol.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Chloramphenicol.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Chloramphenicol.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Chloramphenicol.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Chloramphenicol.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Chloramphenicol.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Chloramphenicol.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Chloramphenicol.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Chloramphenicol.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Chloramphenicol.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Chloramphenicol.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Chloramphenicol is combined with Fluindione.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Chloramphenicol.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Chloramphenicol.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Chloramphenicol.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Chloramphenicol.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Chloramphenicol.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Chloramphenicol.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Chloramphenicol.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Altretamine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Chloramphenicol.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Chloramphenicol.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Nimesulide is combined with Chloramphenicol.]
[C03AA03, hydrochlorothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Chloramphenicol.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Chloramphenicol.]
[C03AA02, hydroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Chloramphenicol.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be decreased when combined with Chloramphenicol.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Chloramphenicol.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Chloramphenicol.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Chloramphenicol.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Chloramphenicol.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Topotecan.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Chloramphenicol.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Chloramphenicol.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Chloramphenicol.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Articaine.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Chloramphenicol.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Chloramphenicol.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Chloramphenicol.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Chloramphenicol.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Chloramphenicol.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Chloramphenicol.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Chloramphenicol.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Chloramphenicol.]
[L04AC07, tocilizumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Tocilizumab.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Chloramphenicol.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Chloramphenicol.]
[L04AA24, abatacept, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Abatacept.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Chloramphenicol.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Chloramphenicol.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Chloramphenicol.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Chloramphenicol.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Chloramphenicol.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Lidocaine.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Chloramphenicol.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Lomustine.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Chloramphenicol.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Chloramphenicol.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Chloramphenicol.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Chloramphenicol.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mechlorethamine.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Chloramphenicol.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Chloramphenicol.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Chloramphenicol.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Melphalan.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Chloramphenicol.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be decreased when combined with Chloramphenicol.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Mepivacaine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Chloramphenicol.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Chloramphenicol.]
[J05AF05, lamivudine, The excretion of Lamivudine can be decreased when combined with Chloramphenicol.]
[H03BB02, methimazole, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pemetrexed.]
[N05CA15, methohexital, The metabolism of Methohexital can be decreased when combined with Chloramphenicol.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methotrexate.]
[C03AA08, methyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Chloramphenicol.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Chloramphenicol.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Chloramphenicol.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Methylprednisolone.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Chloramphenicol.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Chloramphenicol.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Chloramphenicol.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Chloramphenicol.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be decreased when combined with Chloramphenicol.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Chloramphenicol.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chloramphenicol.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Chloramphenicol.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Chloramphenicol.]
[L04AB05, certolizumab pegol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Certolizumab pegol.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Chloramphenicol.]
[L04AA06, mycophenolic acid, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mycophenolic acid.]
[N05CA02, amobarbital, The metabolism of Amobarbital can be decreased when combined with Chloramphenicol.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be increased when it is combined with Chloramphenicol.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Chloramphenicol.]
[L04AC03, anakinra, The risk or severity of adverse effects can be increased when Anakinra is combined with Chloramphenicol.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Chloramphenicol.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Chloramphenicol.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Chloramphenicol.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Chloramphenicol.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Chloramphenicol.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Chloramphenicol.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Chloramphenicol.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Chloramphenicol.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Chloramphenicol.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Chloramphenicol.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Chloramphenicol.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Chloramphenicol.]
[L04AC04, rilonacept, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Chloramphenicol.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Chloramphenicol.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Chloramphenicol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Chloramphenicol.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Chloramphenicol.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Chloramphenicol.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Penicillamine.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Chloramphenicol.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Chloramphenicol.]
[N05CA01, pentobarbital, The metabolism of Pentobarbital can be decreased when combined with Chloramphenicol.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Pentostatin.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Chloramphenicol.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Chloramphenicol.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Chloramphenicol is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Chloramphenicol.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Chloramphenicol.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Chloramphenicol.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be increased when it is combined with Chloramphenicol.]
[L04AB06, golimumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Golimumab.]
[S01AE05, levofloxacin, The excretion of Levofloxacin can be decreased when combined with Chloramphenicol.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Chloramphenicol.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Chloramphenicol.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Chloramphenicol.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Chloramphenicol.]
[J05AE01, saquinavir, The metabolism of Saquinavir can be decreased when combined with Chloramphenicol.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Chloramphenicol.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Chloramphenicol.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Chloramphenicol.]
[L04AC08, canakinumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Chloramphenicol.]
[J05AE03, ritonavir, The metabolism of Ritonavir can be decreased when combined with Chloramphenicol.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Chloramphenicol.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Chloramphenicol.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Prednisone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Prilocaine.]
[N03AA03, primidone, The metabolism of Primidone can be decreased when combined with Chloramphenicol.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Chloramphenicol.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Chloramphenicol.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Chloramphenicol.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Chloramphenicol.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Propylthiouracil.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Chloramphenicol.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Chloramphenicol.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Chloramphenicol.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Chloramphenicol.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Chloramphenicol.]
[P01BC01, quinine, The metabolism of Quinine can be decreased when combined with Chloramphenicol.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Chloramphenicol.]
[J04AB02, rifampin, The metabolism of Chloramphenicol can be increased when combined with Rifampicin.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Sulfasalazine.]
[N05CA06, secobarbital, The metabolism of Secobarbital can be decreased when combined with Chloramphenicol.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Chloramphenicol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Chloramphenicol.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Chloramphenicol.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Chloramphenicol.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydrocortisone butyrate.]
